Company / Operating Income
Nuvalent, Inc. Operating Income History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$414.3M
FY2025
5-year range
-$414.3M / -$45.8M
FY2021-FY2025
Trend
-47.8%
vs FY2024
Sector context
#182 of 204
Health Care
What the data says
Nuvalent, Inc.'s operating income of -$414M is lower than 89% of companies in the Health Care sector (FY2025). Operating Income has declined for 5 consecutive years, from -$17M in FY2020 to -$414M in FY2025.
Based on SEC 10-K filings.
-$414M in FY2025.
Declined from -$149M to -$414M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 11% in Health CareTop 89% of 204This company -$414.3M Sector average $107.7M
▼
-484.6% below sector average
Key checks
Key Insights
- Nuvalent, Inc.'s operating income has declined for 5 consecutive years.
- In FY2025, operating income decreased 47.8% year-over-year.
- Ranks #182 out of 204 companies in the Health Care sector.
- Peak operating income was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 2.94 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$414.3M | -47.8% |
| FY2024 | -$280.4M | -87.5% |
| FY2023 | -$149.5M | -73.6% |
| FY2022 | -$86.1M | -87.9% |
| FY2021 | -$45.8M | -171.0% |
| FY2020 | -$16.9M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026